Type 2 Diabetes Mellitus
📧 Sign up to get email alerts when something new happens for Type 2 Diabetes Mellitus.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2023-08-15Clinical Trial Update: Renal HEIR Study: Renal Hemodynamics, Energetics and Insulin Resistance in Youth Onset Type 2 Diabetes Study [Phase 1, Phase 2]
A study investigating renal hemodynamics, energetics, and insulin resistance in youth-onset type 2 diabetes, spanning Phase 1 and Phase 2.
-
CLINICAL_TRIALS trial_result · 2023-08-14Clinical Trial Update: Effect of Fimasartan on Extended RAS and Vascular Functions in Patients With Type 2 Diabetes and Hypertension [Phase 4]
Phase 4 clinical trial evaluating the effect of fimasartan on extended RAS and vascular functions in patients with type 2 diabetes and hyper…
-
CLINICAL_TRIALS trial_result · 2023-08-14Clinical Trial Update: Effect of Olmesartan on Angiotensin(1-7) Levels and Vascular Functions in Diabetes and Hypertension [Phase 4]
Phase 4 trial evaluating the effect of olmesartan on Angiotensin(1-7) levels and vascular functions in patients with diabetes and hypertensi…
-
CLINICAL_TRIALS trial_result · 2023-08-14Clinical Trial Update: Comparison of Dapagliflozin, Lobeglitazone, and Its Combination in Efficacy and Safety [Phase 4]
Phase 4 trial update comparing dapagliflozin, lobeglitazone, and their combination in type 2 diabetes, focusing on efficacy and safety with …
-
FDA approval · 2023-08-09FDA Approved: SAXAGLIPTIN AND METFORMIN HYDROCHLORIDE — Original Application (Dr.Reddys Laboratories Inc)
FDA approved the original application for saxagliptin and metformin hydrochloride tablets from Dr. Reddy's Laboratories Inc.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2023-08-01Clinical Trial Update: Comparison of the Effects of Dapagliflozin and Gemigliptin on Ketone Metabolism and Cardiac Remodeling in Type 2 Diabetes [Phase 4]
Phase 4 trial comparing dapagliflozin and gemigliptin on ketone metabolism and cardiac remodeling in type 2 diabetes.
-
CLINICAL_TRIALS trial_result · 2023-08-01Clinical Trial Update: Title: Therapeutic Targets in African-American Youth With Type 2 Diabetes [Phase 1, Phase 2]
Phase 1/2 trial investigating therapeutic targets in African-American youth with type 2 diabetes; study completed with results posted in 202…
-
FDA approval · 2023-07-31FDA Approved: SAXAGLIPTIN — Original Application (Mylan Pharmaceuticals Inc.)
FDA approved the original application for saxagliptin by Mylan Pharmaceuticals Inc., enabling a generic version of the diabetes medication f…
-
FDA approval · 2023-07-31FDA Approved: SAXAGLIPTIN — Original Application (Aurobindo Pharma Limited)
The FDA approved a new original ANDA for saxagliptin from Aurobindo Pharma Limited, providing a generic version of the diabetes medication.
-
FDA approval · 2023-07-31FDA Approved: SAXAGLIPTIN — Original Application (Glenmark Pharmaceuticals Inc., USA)
The FDA approved Glenmark's original Abbreviated New Drug Application for saxagliptin (generic) to treat type 2 diabetes mellitus.
-
FDA approval · 2023-07-31FDA Approved: SAXAGLIPTIN AND METFORMIN — Original Application (Mylan Pharmaceuticals Inc.)
The FDA approved the original application for a generic fixed-dose combination of saxagliptin and metformin (SAXAGLIPTIN AND METFORMIN) from…
-
CLINICAL_TRIALS trial_result · 2023-07-28Clinical Trial Update: Safety and Efficacy of Pegylated Exenatine Injection (PB-119) in Drug-naïve T2DM Subjects [Phase 3]
A Phase 3 trial evaluating the safety and efficacy of Pegylated Exenatine Injection (PB-119) in drug-naïve patients with type 2 diabetes mel…
-
CLINICAL_TRIALS trial_result · 2023-07-28Clinical Trial Update: Safety and Efficacy of PB-119 in Subjects With Type 2 Diabetes and Not Well-controlled by Metformin Monotherapy [Phase 3]
Phase 3 trial assessing PB-119 safety and efficacy in adults with Type 2 Diabetes not adequately controlled on metformin alone.
-
CLINICAL_TRIALS trial_result · 2023-07-28Clinical Trial Update: Sitagliptin for the Treatment of Type 2 Diabetes [Phase 4]
Clinical trial update for sitagliptin in type 2 diabetes (Phase 4).
-
CLINICAL_TRIALS trial_result · 2023-07-27Clinical Trial Update: Research Study to Look at How Well Cagrilintide Together With Semaglutide Works in People With Type 2 Diabetes [Phase 2]
A Phase 2 study evaluated the combination of cagrilintide and semaglutide in people with type 2 diabetes; results have been posted.
-
FDA approval · 2023-07-27FDA Approved: ALOGLIPTIN — Supplemental Application (Padagis Israel Pharmaceuticals Ltd)
The FDA approved a supplemental application for alogliptin by Padagis Israel Pharmaceuticals Ltd.
-
FDA approval · 2023-07-27FDA Approved: KAZANO — Supplemental Application (Takeda Pharmaceuticals America, Inc.)
FDA approved a supplemental application for Kazano (alogliptin/metformin hydrochloride) submitted by Takeda Pharmaceuticals America, Inc.
-
CLINICAL_TRIALS trial_result · 2023-07-25Clinical Trial Update: Semaglutide and Vascular Regeneration [Phase 4]
Phase 4 trial update investigating semaglutide for vascular regeneration in patients with atherosclerosis and cardiovascular diseases, with …
-
CLINICAL_TRIALS trial_result · 2023-07-24Clinical Trial Update: Can Exenatide Prevent Increase in EGP in Response to Dapagliflozin-induced Increase in Glucosuria [Phase 4]
A Phase 4 clinical trial evaluating whether exenatide can prevent an increase in endogenous glucose production when dapagliflozin increases …
-
EMA approval · 2023-07-21EMA Authorised: Vipidia (alogliptin) — Takeda Pharma A/S
The EMA authorises Vipidia (alogliptin) for type 2 diabetes mellitus, with Takeda Pharma A/S as the marketing authorization holder.
-
FDA approval · 2023-07-21FDA Approved: INSULIN LISPRO — Supplemental Application (Eli Lilly and Company)
FDA approves a supplemental application for insulin lispro submitted by Eli Lilly and Company.
-
FDA approval · 2023-07-21FDA Approved: HUMALOG MIX50/50 KWIKPEN — Supplemental Application (Eli Lilly and Company)
The FDA approved a supplemental application for Humalog Mix50/50 KwikPen (insulin lispro) from Eli Lilly and Company. Insulin lispro is used…
-
FDA approval · 2023-07-21FDA Approved: HUMALOG KWIKPEN — Supplemental Application (Eli Lilly and Company)
FDA approved a supplemental application for HUMALOG KWIKPEN (insulin lispro) from Eli Lilly and Company.
-
FDA approval · 2023-07-21FDA Approved: HUMALOG MIX75/25 — Supplemental Application (Eli Lilly and Company)
FDA approved a supplemental application for HUMALOG MIX75/25 (insulin lispro) from Eli Lilly and Company.
-
CLINICAL_TRIALS trial_result · 2023-07-20Clinical Trial Update: Effect of Chronic Exenatide Therapy on Beta Cell Function and Insulin Sensitivity in T2DM [Phase 4]
Phase 4 trial assessing how chronic exenatide therapy influences beta cell function and insulin sensitivity in adults with type 2 diabetes.